Clinical Trials Browser

Phase 3 × PM 01183 × 30 days × Clear all

NCT07625644 2026-06-04

Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT06203210 2026-06-02

IDeate-Lung02

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06801834 2026-05-20

EVOKE-SCLC-04

Phase 3 Recruiting

Extensive Stage Small Cell Lung Cancer (ES-SCLC)